- BioPorto announces preliminary results for 2023 and provides strategic update for the period 2024-2026
- Roche Diagnostics and BioPorto expand collaboration
- BioPorto implements changes to the Executive Management.
- Managers’ transactions
- BioPorto Receives FDA 510(k) Clearance for NGAL Test in the United States First Test to Aid in Assessing AKI Risk for Patients Aged 3 Months Through 21 Years
- Resignation of Director
- BioPorto Announces Interim Results and Business Update For the Third Quarter and Nine Months of Fiscal 2023
- BioPorto provides interim Q3 results and revised 2023 Financial Guidance.
- Grant of Warrants
- BioPorto Initiates Search for new CFO as Neil Goldman Resigns
More ▼
Key statistics
On Wednesday, Bioporto A/S (BIOPOR:CPH) closed at 1.31, 22.24% above the 52 week low of 1.07 set on Jun 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.31 |
---|---|
High | 1.34 |
Low | 1.31 |
Bid | -- |
Offer | -- |
Previous close | 1.34 |
Average volume | 461.48k |
---|---|
Shares outstanding | 379.67m |
Free float | 338.56m |
P/E (TTM) | -- |
Market cap | 496.61m DKK |
EPS (TTM) | -0.1947 DKK |
Data delayed at least 15 minutes, as of Mar 27 2024 15:59 BST.
More ▼